ReviewTheranostics2023
Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy.
Shuangneng Yin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
48 papers cite it
this papercites it
ReviewTheranostics2023
Shuangneng Yin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.